BIIB Biogen Inc. | US09062X1037
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 10.318.175.650 | 10.063.883.870 | 2.53% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 16,42 | 11,98 | 37.02% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 28 | 29 | 3.45% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |